List of works - Dan Henrohn

A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial

scientific article published in May 2009

Acute haemodynamic response in relation to plasma vardenafil concentrations in patients with pulmonary hypertension

scientific article

Acute vasodilator response to vardenafil and clinical outcome in patients with pulmonary hypertension

scientific article published on 5 August 2015

Age-based (<65 vs ≥65 years) incidence of infections and serious infections with tofacitinib versus biological DMARDs in rheumatoid arthritis clinical trials and the US Corrona RA registry

scientific article published on 12 October 2020

Changes in plasma levels of asymmetric dimethylarginine, symmetric dimethylarginine, and arginine after a single dose of vardenafil in patients with pulmonary hypertension

scientific article published on 29 April 2015

Effects of Oral Supplementation With Nitrate-Rich Beetroot Juice in Patients With Pulmonary Arterial Hypertension-Results From BEET-PAH, an Exploratory Randomized, Double-Blind, Placebo-Controlled, Crossover Study

scientific article published on 20 September 2018

Effects of inorganic nitrate in a rat model of monocrotaline-induced pulmonary arterial hypertension

scientific article published on 12 September 2019

Effects of pharmacists' interventions on appropriateness of prescribing and evaluation of the instruments' (MAI, STOPP and STARTs') ability to predict hospitalization--analyses from a randomized controlled trial

scientific article

Increased plasma and salivary nitrite and decreased bronchial contribution to exhaled NO in pulmonary arterial hypertension

scientific article published on 25 February 2011

Lack of evidence of stimulatory autoantibodies to platelet-derived growth factor receptor in patients with systemic sclerosis

scientific article published on April 2009

Mycophenolate mofetil for systemic sclerosis: drug exposure exhibits considerable inter-individual variation-a prospective, observational study

scientific article published on 06 October 2020

Patient's global assessment of disease activity and patient's assessment of general health for rheumatoid arthritis activity assessment: are they equivalent?

scientific article published on 24 April 2012

Plasma L-arginine levels distinguish pulmonary arterial hypertension from left ventricular systolic dysfunction

scientific article published on 3 October 2017

The association of fatigue, comorbidity burden, disease activity, disability and gross domestic product in patients with rheumatoid arthritis. Results from 34 countries participating in the Quest-RA program

article

Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study

scientific article published on 14 January 2009

Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA study

scientific article

[Cardiovascular risk in inflammatory systemic disease should be assessed regularly. The Swedish Society of Rheumatology has formulated guidelines for primary prevention]

scientific article published on 01 January 2012

List of works by Dan Henrohn

A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial

Acute haemodynamic response in relation to plasma vardenafil concentrations in patients with pulmonary hypertension

Acute vasodilator response to vardenafil and clinical outcome in patients with pulmonary hypertension

Age-based (<65 vs ≥65 years) incidence of infections and serious infections with tofacitinib versus biological DMARDs in rheumatoid arthritis clinical trials and the US Corrona RA registry

Changes in plasma levels of asymmetric dimethylarginine, symmetric dimethylarginine, and arginine after a single dose of vardenafil in patients with pulmonary hypertension

Effects of Oral Supplementation With Nitrate-Rich Beetroot Juice in Patients With Pulmonary Arterial Hypertension-Results From BEET-PAH, an Exploratory Randomized, Double-Blind, Placebo-Controlled, Crossover Study

Effects of inorganic nitrate in a rat model of monocrotaline-induced pulmonary arterial hypertension

Effects of pharmacists' interventions on appropriateness of prescribing and evaluation of the instruments' (MAI, STOPP and STARTs') ability to predict hospitalization--analyses from a randomized controlled trial

Increased plasma and salivary nitrite and decreased bronchial contribution to exhaled NO in pulmonary arterial hypertension

Lack of evidence of stimulatory autoantibodies to platelet-derived growth factor receptor in patients with systemic sclerosis

Mycophenolate mofetil for systemic sclerosis: drug exposure exhibits considerable inter-individual variation-a prospective, observational study

Patient's global assessment of disease activity and patient's assessment of general health for rheumatoid arthritis activity assessment: are they equivalent?

Plasma L-arginine levels distinguish pulmonary arterial hypertension from left ventricular systolic dysfunction

The association of fatigue, comorbidity burden, disease activity, disability and gross domestic product in patients with rheumatoid arthritis. Results from 34 countries participating in the Quest-RA program

Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study

Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA study

[Cardiovascular risk in inflammatory systemic disease should be assessed regularly. The Swedish Society of Rheumatology has formulated guidelines for primary prevention]